Jianping Cai

938 total citations
37 papers, 676 citations indexed

About

Jianping Cai is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmacology. According to data from OpenAlex, Jianping Cai has authored 37 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Jianping Cai's work include Boron Compounds in Chemistry (12 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Jianping Cai is often cited by papers focused on Boron Compounds in Chemistry (12 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Jianping Cai collaborates with scholars based in China, United States and Japan. Jianping Cai's co-authors include Yoshinori Yamamoto, Hisao Nemoto, Mark S. Soloway, Robert A. Goodnow, Yi Chen, Rolf F. Barth, Ann Petersen, Dianne M. Adams, Agnieszka Kowalczyk and Alexander L. Satz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Jianping Cai

35 papers receiving 652 citations

Peers

Jianping Cai

RNMI

PHARM

Hiroyuki Masuno Japan

Shashikanth Ponnala United States

Hsiou‐Ting Kuo Canada

Nigel R. A. Beeley United Kingdom

Wasyl Halczenko United States

Adrian L. Gill United Kingdom

Richard T. Dean United States

S. W. BALDWIN United States

Przemysław Koźmiński Poland

Tanja Peters Germany

Hiroyuki Masuno Japan

Jianping Cai

309 ×1.0

164 ×0.6

RNMI

219 ×1.0

73 ×0.6

59 ×0.8

PHARM

Citations per year, relative to Jianping Cai Jianping Cai (= 1×) peers Hiroyuki Masuno

Countries citing papers authored by Jianping Cai

Since Specialization

Citations

This map shows the geographic impact of Jianping Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Cai more than expected).

Fields of papers citing papers by Jianping Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianping Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Cai. The network helps show where Jianping Cai may publish in the future.

Co-authorship network of co-authors of Jianping Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Cai. A scholar is included among the top collaborators of Jianping Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Cai. Jianping Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lei, Wanying, et al.. (2025). Mesenchymal and Pluripotent Stem Cell‐Based Strategies for Cardiac Regeneration: Mechanisms, Challenges, and Future Directions. Biotechnology Journal. 20(11). e70152–e70152.

Yang, Hangsheng, Binbin Cheng, Zhao‐Yang Lu, et al.. (2025). Discovery of highly potent dual GSPT1/BRD4 degraders with anti-AML activity. European Journal of Medicinal Chemistry. 288. 117381–117381. 8 indexed citations

Wang, Jing, Xiaoyu Xu, Xinyue Li, et al.. (2024). The impact of CYP3A4 genetic polymorphism on crizotinib metabolism and drug-drug interactions. Toxicology and Applied Pharmacology. 489. 117016–117016.

Zhang, Qing, Shuanghu Wang, Lili Zou, et al.. (2023). Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects. Frontiers in Endocrinology. 14. 6 indexed citations

Zhang, Xiaodan, Qingqing Li, Quan Zhou, et al.. (2023). Determine the enzymatic kinetic characteristics of CYP3A4 variants utilizing artemether-lumefantrine. Food and Chemical Toxicology. 181. 114065–114065. 1 indexed citations

Hu, Xiaoqin, et al.. (2022). The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline. Chemico-Biological Interactions. 366. 110123–110123. 7 indexed citations

Sun, Wei, Pengchong Li, Jianping Cai, et al.. (2022). Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus. Frontiers in Immunology. 13. 860586–860586. 39 indexed citations

Zhang, Xiaodan, et al.. (2022). The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism. Frontiers in Pharmacology. 13. 794931–794931. 16 indexed citations

Liu, Yanan, Yingying Hu, Jing Wang, et al.. (2022). Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics. Frontiers in Pharmacology. 13. 991281–991281. 2 indexed citations

10.

Han, Mingming, Xiaodan Zhang, Jing Wang, et al.. (2021). Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro. Chemico-Biological Interactions. 350. 109700–109700. 6 indexed citations

11.

Han, Mingming, et al.. (2021). Functional assessment of the effects of CYP3A4 variants on acalabrutinib metabolism in vitro. Chemico-Biological Interactions. 345. 109559–109559. 11 indexed citations

12.

Xu, Ren-ai, et al.. (2018). The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro. Infection and Drug Resistance. Volume 11. 2129–2135. 16 indexed citations

13.

Zhou, X.‐Y., Zhe Chen, Pengfei Tang, et al.. (2017). Determination of lesinurad in rat plasma by a UHPLC–MS/MS assay. Chemistry Central Journal. 11(1). 121–121. 6 indexed citations

14.

Fang, Ping, et al.. (2017). Effects of CYP2C19 Variants on Fluoxetine Metabolism in vitro. Pharmacology. 100(1-2). 91–97. 5 indexed citations

15.

Hu, Xiaoxia, et al.. (2016). A rapid and sensitive UHPLC–MS/MS assay for the determination of trelagliptin in rat plasma and its application to a pharmacokinetic study. Journal of Chromatography B. 1033-1034. 166–171. 10 indexed citations

16.

Zeng-shou, Wang, Liping Yang, Da‐Peng Dai, et al.. (2015). In Vitro and In Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population. Drug Metabolism and Disposition. 43(4). 561–569. 12 indexed citations

17.

Chen, Mengchun, Hui Jin, Mengming Xia, et al.. (2014). Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism. Drug Metabolism and Disposition. 42(11). 1820–1825. 16 indexed citations

18.

Chen, Shaoqing, David Bartkovitz, Jianping Cai, et al.. (2011). Identification of novel, potent and selective inhibitors of Polo-like kinase 1. Bioorganic & Medicinal Chemistry Letters. 22(2). 1247–1250. 22 indexed citations

19.

Nakamura, Hiroyuki, Kouichi Aoyagi, Bakthan Singaram, et al.. (1997). A Novel [3+2] Annelation between ortho ‐Carboranyltrimethylsilane and Conjugated Carbonyl Compounds. Angewandte Chemie International Edition in English. 36(4). 367–369. 14 indexed citations

20.

Nemoto, Hisao, et al.. (1995). Synthesis and Biological Properties of Water-Soluble p-Boronophenylalanine Derivatives. Relationship between Water Solubility, Cytotoxicity, and Cellular Uptake. Journal of Medicinal Chemistry. 38(10). 1673–1678. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact